Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Professor Paul Turner

Professor Paul Turner

Podcast Interview

Infectious diseases are prevalent in Cambodia, a country that is struggling with poor infrastructure. Streptococcus pneumoniae causes the most severe form of pneumonia and is now targeted by the pneumococcal conjugate vaccine. Dr Paul Turner is studying the effect of this vaccine in field conditions in SE Asia, as well as other direct applications such as the evaluation of a new diagnostic test for Typhoid and interventions to reduce the burden of infections acquired within hospitals.

Social media

Paul Turner

MB BS, PhD, FRCPCH, FRCPath


Associate Professor

  • Senior Clinical Research Fellow
  • Consultant in Microbiology
  • Director of the Cambodia Oxford Medical Research Unit

Clinical microbiologist with a focus on paediatric infections

Paul Turner is based at the Cambodia-Oxford Medical Research Unit (COMRU), Angkor Hospital for Children in Siem Reap, Cambodia.

His research interests include:

  • Antimicrobial resistance surveillance and control;
  • Paediatric healthcare associated infections;
  • Pneumococcal colonisation and disease and the impact of pneumococcal vaccines;
  • Utilisation of bacterial colonisation data.

His non-research work focuses on development of human and laboratory capacity for diagnostic microbiology in low-resource settings.

Key publications

Recent publications

More publications